Login / Signup
Wei Han
(Jie Lu)
ORCID
Publication Activity (10 Years)
Years Active: 2021-2023
Publications (10 Years): 4
Top Topics
Signaling Pathway
Acute Respiratory Distress Syndrome
Pi K Akt
Cell Proliferation
Top Venues
PPAR research
Journal of drug targeting
Journal of translational medicine
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Wenyan Yu
,
Zhuning Wang
,
Ping Dai
,
Jing Sun
,
Jian Li
,
Wei Han
,
Kaichun Li
The activation of SIRT1 by resveratrol reduces breast cancer metastasis to lung through inhibiting neutrophil extracellular traps.
Journal of drug targeting
(2023)
Wei Han
,
Nan Wang
,
Rui Kong
,
Wen Bao
,
Wei Han
Ligand-activated PPARδ expression promotes hepatocellular carcinoma progression by regulating the PI3K-AKT signaling pathway.
Journal of translational medicine
20 (1) (2022)
Rui Kong
,
Nan Wang
,
Wei Han
,
Wen Bao
,
Jie Lu
Fenofibrate Exerts Antitumor Effects in Colon Cancer via Regulation of DNMT1 and CDKN2A.
PPAR research
2021 (2021)
Wen Bao
,
Rui Kong
,
Nan Wang
,
Wei Han
,
Jie Lu
PPAR-Alpha Agonist Fenofibrate Combined with Octreotide Acetate in the Treatment of Acute Hyperlipidemia Pancreatitis.
PPAR research
2021 (2021)